Skip to main content

Day: August 22, 2023

Virtualware nominated for 2023 Outstanding VR Company of the Year

Bilbao, August 22, 2023. – The Academy of International Extended Reality (AIXR) has announced the finalists for the 7th International VR Awards, naming Virtualware finalist for “Outstanding VR company of the Year”. The awards ceremony will take place on November 30, 2023 in Rotterdam, Netherlands at Immersive Tech Week, in a magic night to remember and showcase the incredible leaps and bounds in VR development across the globe. The year 2023 has unfolded as a testament to the Virtualware´s relentless pursuit of excellence, culminating in its nomination for a prestigious VR Awards. This recognition stands as a testament to Virtualware’s commitment to pushing the boundaries of virtual reality technology. Some of the significant accomplishments this year have been Virtualware’s successful listing on Euronext Access Paris on April...

Continue reading

KBC Group: Update regarding the KBC Group share buyback programme

Within the framework of the share buyback programme, announced on 10 August 2023 after trading hours, KBC Group NV wishes to advise that the following transactions took place on NYSE Euronext Brussels’ regulated market between 11 August 2023 and 18 August 2023 included:Date No. of shares Total price Average price Lowest price Highest price11-08-2023 85.000 5.513.559 € 64,87 € 64,44 € 65,50 €14-08-2023 63.000 4.112.489 € 65,28 € 64,24 € 65,64 €15-08-2023 50.000 3.247.360 € 64,95 € 64,84 € 65,30 €16-08-2023 96.000 6.109.920 € 63,65 € 63,18 € 64,62 €17-08-2023 90.000 5.664.501 € 62,94 € 62,46 € 63,44 €18-08-2023 86.265 5.361.370 € 62,15 € 61,74 € 62,52 €Following these transactions, the total number of own shares held by KBC Group NV within the framework of the share buyback programme amounted to 470.265 on 18 August...

Continue reading

Ultimovacs ASA Reports Second Quarter 2023 Financial Results and Provides General Business Update

Oslo, 22 August 2023: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, announces its second quarter 2023 results today. “In the first half of this year, Ultimovacs has further advanced the broad evaluation of our therapeutic cancer vaccine UV1 across key indications. Our UV1-103 study in the U.S. continues to demonstrate encouraging and lasting patient survival, a direct measure of clinical benefit in cancer trials. In addition, we recently reached an important milestone with three randomized Phase II studies fully enrolled in different cancer indications. We are eagerly awaiting the forthcoming data these trials will provide, helping us better comprehend UV1’s potential and the benefits it can provide in the clinical outcomes for the patients,” said...

Continue reading

AKVA group ASA: Acquisition of controlling ownership in Submerged AS

AKVA group ASA (AKVA) is pleased to announce the acquisition of 51% of the shares in Submerged AS (Submerged) to further strengthen its digital capabilities. Submerged has successfully developed and commercialized a camera system and software for fish-welfare, lice counting and biomass measurement. AKVA has the option to acquire 100% shares in Submerged in 2028 based on certain conditions. Knut Nesse, CEO of AKVA: “The acquisition of the majority stake in Submerged is of great strategic importance to AKVA and will further develop and complement our digital offerings to the market. By combining Submerged with our current digital products such as AKVA Fishtalk, AKVA Observe and AKVA Connect we are strengthening our AKVA Fusion® platform and can now offer a complete digital solution to enhance precision fish farming” Dated: 22 August 2023AKVA...

Continue reading

Ubisoft Signs Deal for Streaming Call of Duty and Other Activision Blizzard Games

 Ubisoft Signs Deal for Streaming Call of Duty and Other Activision Blizzard Games Cloud Streaming Agreement Will Enable Players to Stream Activision Blizzard Titles via a Wide Range of Subscriptions and Services, including Ubisoft+  PARIS – August 22, 2023 – Today, Ubisoft announced a transaction giving Ubisoft the cloud streaming rights for Call of Duty and all other Activision Blizzard titles releasing over the next 15 years once Microsoft’s acquisition of Activision Blizzard is completed. This will enable Ubisoft to bring cloud streaming access of Activision Blizzard games to more players all around the world. These rights will exist in perpetuity.     These rights will further strengthen Ubisoft’s content offering through its subscription service Ubisoft+, as well as allowing Ubisoft to license...

Continue reading

Cabka 2023 Half Year: Profitable revenue growth to € 104 million with net income from operations at € 3 million

Amsterdam August 22, 2023. Cabka N.V. (together with its subsidiaries, the “Company”) a company specialized in transforming hard to recycle plastic waste into innovative Reusable Transport Packaging (RTP), listed at Euronext Amsterdam, announces its non-audited results for the first six months ended June 30, 2023 (“2023HY”), today.1 Highlights 2023 Half YearSales of € 104.3 million representing a 2% Year-on-Year (YoY) growth Gross profit from operations increased to € 50.8 million (2022HY: € 47.3 million) representing an improved margin of 49% over sales compared to last year (2022HY: 46%) EBITDA from operations at € 13.4 million (2022HY: € 13.1 million) at 13% (2022HY: 13%), recovering from a volatile second half of 2022 Net Income from operations showing recovery to € 3.0 million (2022HY: € 0.7million) Net result € 0.8 million, recovering...

Continue reading

29/2023 Green Hydrogen Systems – Interim report H1 2023

Company announcement 29/2023 Green Hydrogen Systems – Interim report for H1 2023 Business highlightsIn the first half of 2023, two A-Series customer orders were revenue recognised, totalling DKK 14 million in revenueSince Q1 2023, delivered electrolysers have been site acceptance tested and are commissioned for commercial production of green hydrogen at customer sites in Chile, Norway and DenmarkIn H1 2023, two orders from international customers of 7.2MW and 0.9MW were signed with targeted delivery end of 2023 and beginning of 2024The X-Series prototype has been installed at the GreenLab facility in Skive, Denmark. Commissioning is progressing well, with several component and system tests already done towards targeted commercial launch in Q4 2023During the first half of 2023, the expansion to a 400 MW electrolyser manufacturing...

Continue reading

Electroceuticals Market to Surpass 27.37 Billion by 2030 Drives Due to Increasing Prevalence of Cardiovascular Diseases

SkyQuest projects that the electroceuticals market will attain a value of USD 27.37 billion by 2030, with a CAGR of 5.02% over the forecast period (2023-2030). The global electroceuticals market is experiencing significant growth, primarily driven by the increasing prevalence of cardiovascular diseases. Cardiovascular diseases are recognized as a leading cause of mortality worldwide, posing a significant health burden. According to the World Health Organization, these diseases are responsible for more than 17.3 million deaths annually. Westford, USA, Aug. 21, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the geriatric population faces a higher risk of developing neurologic or cardiovascular disorders due to their advanced age. This vulnerability to such disorders makes the geriatric segment a crucial part of the overall patient...

Continue reading

Perseus FY23 financial results webinar

perth, Aug. 22, 2023 (GLOBE NEWSWIRE) — FY2023 RESULTS INVESTOR WEBINAR / CALL Perth, Western Australia/22 August 2023/ Perseus Mining Limited (ASX/TSX: PRU) is hosting an investor webinar and conference call to discuss its FY23 financial results, which are anticipated for release around 8:30am AEST on Thursday August 31, 2023. CALL DETAILSAustralia: Thursday August 31, 2023 Perth – 7:00am Sydney/Melbourne – 9:00am Canada: Wednesday August 30, 2023 Vancouver – 4:00pm Toronto – 7:00pm UK: Thursday August 31, 2023 London – 12:00amRegister for the investor webinar at the link below: https://us02web.zoom.us/webinar/register/WN_ERATsNO9TO2WODRnoYBoXg After registering, you will receive a confirmation email containing information about joining the webinar. To join the webinar via telephone, please use one of the following numbers...

Continue reading

Handwriting Digital Pen Market Set to Soar Past USD 6.4 Billion by 2030

The global Handwriting Digital Pen market size is expected to reach USD 6.4 billion by 2030 and exhibit a CAGR of 13.6% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing adoption of digital transformation in various industries, growing demand for seamless integration of digital and physical note-taking, rising need for accurate and efficient data entry and annotation, rising popularity of digital art and graphic design, and growing emphasis on productivity and organization, are fueling the market’s growth. Westford, USA, Aug. 21, 2023 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Handwriting Digital Pen market,  integration with digital devices and platforms, development of smart pens with advanced features, increasing popularity of note-taking...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.